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ABSTRACT 
Objective: Methotrexate is an effective treatment for autoimmune diseases like Rheumatoid arthritis, vasculitis, and Psoriasis. Our aim is to do in 
silico screening of various phytochemicals present in common medicinal plants used in India for arthritis and fever for possible Dihydrofolate 
reductase (DHFR) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) Transformylase inhibitory property similar to methotrexate 
(MTX) using molecular docking method. 
Methods: We did docking of 142 phytochemicals against DHFR and AICAR Transformylase domain of ATIC (AICAR Transformylase/Inosine 
monophosphate cyclohydrolase) enzyme structures extracted from Protein Data Bank (4M6K, 1P4R respectively), by utilizing the Molegro virtual 
docker Software. The docking scores of phytochemicals were compared with the scores of respective native reference ligands present in the crystal 
structures. 
Results: Compounds, dicrocin, melianone, calotropin, uscharidin and mauritine A showed more negative moldoc and rerank scores compared to 
folic acid and MTX when docked in the folate-binding pocket of DHFR. Dicrocin, melianone and hecogenin showed more negative moldoc and rerank 
scores compared to scores of AICAR and MTX, when docked in the cavity in AICAR Transformylase, which binds AICAR.  
Conclusion: The protein-ligand interaction plays a significant role in structural based drug designing. The present analysis shows that Melianone 
and dicrocin could be the potential lead molecules for the inhibition of both DHFR and AICAR transformylase like MTX. Uscharidin, calotropin, and 
mauritine A may be the potential DHFR inhibitor lead molecules and Hecogenin could be the potential lead molecule for inhibition of AICAR 
transformylase. 
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INTRODUCTION 
Mechanism of action of methotrexate (MTX) 
Folic acid is an important cofactor for various enzymes involved in 
DNA synthesis. Various drugs which antagonise folic acid and 
thereby interfere with DNA synthesis and cell division have been 
tried for treatment of cancers and some autoimmune diseases. 
Prototype among these drugs is methotrexate (MTX). MTX is a folate 
analogue originally synthesised in the 1940s and designed to inhibit 
dihydrofolate reductase [1]. MTX binds dihydrofolate reductase 
(DHFR) with high affinity and has a fairly high affinity for enzymes 
that require folate cofactors, including thymidylate synthetase 
(TS). MTX inhibits dihydrofolate reductase (DHFR), an enzyme 
responsible for the conversion of dihydrofolate (DHF) to 
tetrahydrofolate (THF) which acts as the proximal single carbon 
donor in several reactions involved in the de novo synthetic 
pathways for pyrimidines and purines, including thymidylate 
synthesis by TS [2, 3]. Consequently, there is a reduction in 
thymidylate and purines in dividing cells. DNA synthesis 
eventually halts, and cells can no longer replicate. In 1951 the 
rationale for the introduction of MTX for the treatment of 
rheumatoid arthritis (RA) was that it inhibited cell division and 
proliferation of the lymphocytes and other cells responsible for 
inflammation in the joint [4, 5]. 
MTX action on adenosine pathway 
MTX also works on the adenosine pathway by inhibiting enzyme Amino-
imidazole-4-carboxamide ribonucleotide (AICAR) transformylase/ IMP 
cyclohydrolase (ATIC). ATIC is a bifunctional enzyme with folate-
dependent AICAR transformylase and IMP cyclohydrolase activities 
that catalyzes the last two steps of purine synthesis. AICAR 
transformylase inhibition by MTX leads to intracellular 
accumulation of AICAR [6] and ultimately leads to increased levels of 
adenosine. Adenosine is a potent inhibitor of inflammation and 
induces vasodilation. Adenosine’s anti-inflammatory effects include 
regulation of endothelial cell functions; including cell trafficking 
resulting in decreased leukocyte accumulation in inflamed sites [6-
8]. This effect of MTX does not seem to be affected by folate 
supplementation.  
Side effects of MTX and need for alternative drugs 
Polyglutamation of this drug prolongs its intracellular presence. An 
increase in polyglutamation results in an abnormal increase in the 
intracellular concentration of MTX on the prolonged use and thereby 
results in increased risk of toxicity as a result of direct, prolonged 
intracellular exposure [9, 10]. Myeloid lineage cells such as leukemic 
myeloblasts, megakaryocytes, synovial macrophages, lymphoblasts, 
and epithelia are more susceptible to this medication consequently 
patients may experience MTX toxicity in the form of liver damage 
mucositis and pancytopenia. Various plant compounds and 
preparations are being used in Indian system of medicine for 
treatment of autoimmune diseases like Rheumatoid arthritis, 
vasculitis, and Psoriasis. These diseases are chronic and have a 
tendency to relapse after treatment. Since MTX is an effective 
treatment of these autoimmune diseases, we postulated that some of 
the plant products may contain phytochemicals with MTX like action 
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and screened plant products for phytochemicals which have MTX 
like action so that people who have intolerance to MTX can be 
substituted with these products.  
Currently, molecular docking approach has been used in modern 
drug design and to understand drug-receptor interactions. This 
paper reports screening of various phytochemicals present in 
common medicinal plants used in India for arthritis and fever for 
DHFR and AICAR Transformylase inhibitory property similar to 
MTX, by utilizing the Molegro Virtual Docker (MVD) Software [11]. 
MATERIALS AND METHODS 
The structures of DHFR (PDB ID 4M6K) and AICAR Trans formylase 
in complex with Inosine Cyclohydrolase (ATIC-PDB ID 1P4R) were 
obtained from the Protein Data Bank (http//;www.rcsb.org). The 
4M6K structure contains folic acid co-crystallised to DHFR. The 
1P4R structure contains Aminoimidazole 4-carboxamide 
ribonucleotide and xanthosine-5'-monophosphate co-crystallised to 
ATIC. ATIC forms an intertwined dimer with an extensive interface 
of approximately 5,000 Å2 per monomer. Each monomer is 
composed of two novels, separate functional domains. The N-
terminal domain (up to residue 199) is responsible for the IMPCH 
activity, whereas the AICAR Trans formylase activity resides in the 
C-terminal domain (residues 200-593) [12-16]. MVD automatically 
identifies potential binding sites (also referred as cavities or active 
sites) by using its cavity detection algorithm. The cavities within a 
30 x 30 x 30 Å3centered at the experimentally known ligand position 
were used for docking. In the crystal structure of DHFR (4M6K), the 
program identified three different binding sites. From these three 
predicted cavities, Cavity where folic acid binds were identified and 
selected for docking. In the case of the crystal structure of dimer 
ATIC (1P4R), the program identified five different binding sites. 
From these five predicted cavities, two Cavities one in each 
monomer in the C-terminal domain with AICAR Trans formylase 
activity where AICAR molecules bind were selected for docking. 
Native ligands were extracted and re-docked into appropriate active 
sites. The results yielded control parameters for comparing with 
Phytochemicals. Docked native ligands were viewed in workspace 
and were found to have optimal orientation. Literature search was 
done, and List of plants used in native medicine in the region of 
Tamilnadu in India for arthritis was compiled. 34 plants were 
principally used to treat arthritis either as single or polyherbal 
formulations. A further literature search was done and individual 
phytochemicals constituents reported to be present in each of the 
plants were identified. A final list of 142 phytochemicals molecules 
which satisfy at least 4 conditions of the Lipinsky 5 rule (Molecular 
weight<=500 g/mol, Oil/water distribution coefficient (Log P)<= 
5,Hydrogen bond donors<= 5, Hydrogen bond acceptor<=10, 
Number of rotatable bonds<=10) was prepared for docking studies 
[17-20]. The structure of these compounds was downloaded as sdf 
files from PubChem compounds database. In order to make accurate 
predictions, it is important that the imported structures have been 
properly prepared, that is, the atom connectivity and bond orders 
are correct and partial atomic charges are assigned. SDF files often 
have poor or missing assignment of explicit hydrogens.  
All necessary valence checks and H-atom addition were thus 
performed using the utilities provided in MVD. Ten independent 
runs were performed for each phytochemicals with the guided 
differential evolution algorithm, with each of these docking runs 
returning one solution (pose). The Moldock scoring function used by 
MVD is derived from the scoring functions originally proposed by 
Gehlhaar et al. and extended later by Yang et al. [21]. The 10 
solutions obtained from the 10 independent docking runs were re-
ranked, in order to further increase the docking accuracy, by using a 
more complex scoring function. The docking scores of 
phytochemicals in DHF were validated by comparing them with the 
docking scores of folic acid and MTX. The docking scores of 
phytochemicals in ATIC were validated by comparing them with the 
docking scores of AICAR and MTX respectively. In the studies 
reported here, MVD was used, because it showed higher docking 
accuracy when benchmarked against other available docking 
programs (MD: 87%, Glide: 82%, Surflex: 75%, FlexX: 58%) [11]. 
RESULTS AND DISCUSSION 
Table 1 shows the mean Moldoc scores and the re-rank scores for 
each of the docked ligand in DHF. Negative values indicate that the 
bond is more stable. 
 
Table 1: Moldoc scores and Re-rank scores and binding amino acids of docked ligands of DHFR 
S. No. Ligands Moldoc score; kcal/mol Rerank score kcal/mol H-bonds Amino acids 
1 Folic acid -153.299±8.00 -119.943±7.811 9 Lys54,Lys55,Ser119,Ser118,Thr146,Asn64, 
Arg70 
2 MTX -156.825±7.38 -126.633±4.653 7 Glu30, Thr136,Ile7,Val8,Arg70 
3. calotropin -173.365±11.99 -126.475±7.74 4 Thr56,Ser59,Leu22,Arg70 
4. Dicrocin -203.298±5.550 -145.607 ±14.564` 8 Lys54,Lys55,Ser119,Ser118,Thr146,Asn64, 
Arg70 
5. Mauritine a -191.263±5.780 -128.517±9.90 4 Ser59,Arg28,Asp21 
6. Melianone -187.761±4.942 -133.927±4.172 2 Thr56,Ser59 
7. Uscharidin -179.90±10.45 -126.468±7.752 4 Thr56,Ser59,Arg70,Leu22 
 Data are means±SD, n = 10. Aminoacids binding to docked ligand–lysine (Lys), Serine (Ser), Threonine (Thr), Arginine (Arg), Asparagine (Asn), 
Isoleucine (Ile), Valine (Val), Glutamate (Glu), Leucine (Leu),  
 
 
Fig. 1: Melianone 
 
 
Fig. 2: Mauritine A 
 
Fig. 3: Calotropin 
 
 
Fig. 4: Uscharidin 
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Fig. 5: Dicrocin 
 
 
Fig. 6: Melianone in DHFR, secondary structure view 
 
 
Fig. 7: Calotropin, H-bonds with Threonine 56, Arginine 70 
 
Higher negativity means the bond is more stable and the interaction 
may hinder the performance of the enzyme. Among 142 compounds 
docked compounds, dicrocin, melianone, calotropin, uscharidin and 
mauritine A showed more negative moldoc score and rerank score 
compared to folic acid and MTX. Residues Ile7, Leu22, Phe31, Phe34, 
Arg70, and Val115 are present in the folate-binding pocket of DHFR 
[22]. Calotropin and uscharidin bind to Leu22 and Arg70, dicrocin 
binds to Arg70 of the folate binding pocket. Residues 9–24 are 
termed “Met20” or “loop 1” which along with other loops forms the 
major subdomain that surround the active site. 
 
 
Fig. 8: Mauritine A, H-bonds with Serine59, Arginine 28, 
Aspartic acid 21 
 
 
Fig. 9: Dicrocin in DHFR, secondary structure view 
 
The high flexibility of Met20 and other loops near the active site play 
a role in promoting the release of the product, tetrahydrofolate. In 
particular, the Met20 loop helps stabilize the nicotinamide ring of 
the NADPH to promote the transfer of the hydride from NADPH to 
dihydrofolate [23]. Mauritine A binds to Asp21 of the Met20 loop. 
Leu 22 to which calotropin and uscharidin bind is also a part of 
Met20 loop. Ser-59, Ser-118, Asp-145, and Thr-146 are the main 
residues that form the NADPH binding site [24]. Dicrocin binds to 
Thr146 and Ser118, whereas melianone, calotropin and uscharidin 
bind to Ser59 of the NADPH binding site. 
 
Table 2: Mean Moldoc scores and Re-rank scores of docked ligands of AICAR Trans formylase Domain of ATIC 




H-bonds Amino acids 
1 AMZ -150.697±6.564 -121.055±1.441 9 Asp546,Phe315,Asn489,Lys266,Arg451, Met312, Phe541 
 MTX -158.386±8.342 -124.048±1.416 7 Asp242,His267,Asn431,Arg451,Asn547, Phe544, Lys266 
2. melianone -195.050±0.713 -143.053±5.301 3 Arg207,Asn239,Ser313 
3. Dicrocin -195.342±16.338 -134.751±1.527 7 Gly564,Ser563,Gly564,Arg588,Tyr208, Lys358 
4. Hecogenin -175.508±2.197 -130.873±4.071 5 Arg588,Arg451,Asn431,Asn239,Ile238 
Data are means±SD, n = 10. Aminoacids binding to docked ligand–lysine (Lys), Serine (Ser), Arginine (Arg), Isoleucine (Ile), Asparagine (Asn), 
Glycine (glycine), Phenylalanine (Phe), Methionine (Met), Tyrisine (Tyr). 
 
Table 2 shows the Moldoc scores and the re-rank scores for the 
docked ligands in a cavity which binds AICAR present in AICAR 
Trans formylase domain in a monomer of ATIC. The scores were 
identical when docked to the cavity in another monomer. Of 142 
phytochemicals docked Dicrocin, melianone and hecogenin showed 
more negative moldoc score and reranked score compared to scores 
AICAR and MTX for both the cavities. Asn431, Lys266 and His 267 
are key catalytic residues involved in the transformylation reaction 
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by AICAR transformylase. The main chain carbonyl oxygen of 
Phe541 and the side chain guanido nitrogen atoms of Arg451 
hydrogen bond to the 4-carboxamide amino and oxygen groups, 
respectively stabilising AICAR. The side chains of Tyr208, Arg207, 
and Arg588 anchor and neutralize the negatively charged AICAR 
Phosphate facilitating transformylation [25]. Melianone binds to 
Arg-207, Hecogenin binds to Asn431, Arg451 and Arg588. Dicrocin 
binds to Arg588. 
 
Fig. 10: Hecogenin 
 
 
Fig. 11: Melianone in ATIC, Secondary structure view 
 
 
Fig. 12: Hecogenin, H-bonds with Arginine 451 Asn 431, Asn 
239, Isoleucine 238 
 
Melianone is present in of Azadirachta indica (neem) and Melia 
azedarach (chinaberry). Caboni et al. showed that among 
components of Azadirachta indica, melianone exhibited the highest 
cytotoxic activity and antiproliferative activity on the tumorigenic 
cell line A549 [26]. Shailima et al. showed that the cytotoxic 
potential of melianone could be due to binding of DHFR Using 
CHARMM (Chemistry at Harvard Macromolecular Mechanics) 
docking program [27]. We also got similar results by using Molegro 
virtual docker and additionally binding property of melianone to 
ATIC is also elicited in our study. Calotropin and uscharidin are 
phytochemicals present in Pergularia Daemia used in polyherbal 
preparations for arthritis in native medicine in Tamilnadu region in 
India. Mirunalini et al. showed that Pergularia Daemia extract 
showed significant cytotoxicity in oral KB cells in MTT assay 
experiment (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide). Increased level of intracellular reactive oxygen species, 
DNA damage (comet assay), apoptotic death and cell cycle arrest 
were seen in Pergularia daemia extract treated cells [28]. Calotropin 
and Uscharidin present in the extract may contribute to cytotoxicity 
through DHFR inhibition. This property may confer MTX like 
antiarthritic potential by the elimination of cytokine producing 
lymphocytes. However, calotropin at high doses has neurotoxicity 
profile like strychnine [29]. Mauritine A is present in of Ziziphus 
jujube. Huang et al. showed the anti-cancer activity of Zizyphus 
jujuba in human hepatoma cells (HepG2) [30]. Ziziphus jujuba leaves 
extract to possess significant anti-inflammatory activity against 
carrageenan induced rat paw edema [31]. Mauritine A may 
contribute to cytotoxicity and through DHFR inhibition along with 
other phytochemicals present in Ziziphus. Dicrocin (alpha-Crocetin 
diglucosyl ester) Isolated from saffron (Crocus sativus) is a water-
soluble crocetin glycoside, a carotenoid pigment. Saffron has been 
used as a spice for flavouring and colouring food preparations, and 
in Chinese traditional medicine as an anodyne. Dicrocin is 
metabolised to crocetin in gut. Hence, cannot satisfactorily exert its 
binding property to DHFR and ATIC. Newer nano delivery systems 
may be used to overcome this disadvantage. Hecogenin is a 
component of Agave sisalana extract which shows anti-inflammatory 
properties when examined in three acute mouse models (xylene ear 
oedema, hind paw oedema, and pleurisy) and a chronic mouse 
model (granuloma cotton pellet). Hecogenin itself possesses the 
antinociceptive property and attenuates mechanical hyperalgesia by 
blocking the neural transmission of pain at the spinal cord levels and 
by cytokines-inhibition mechanisms [32]. These properties may be 
partly due to Hecogenin action on Adenosine pathway by AICAR 
inhibition. 
CONCLUSION 
The protein-ligand interaction plays a significant role in structural 
based drug designing. In the present work, potential phytochemicals 
with DHFR and AICAR transformylase inhibitory property like MTX 
have been identified. The present analysis shows that Melianone and 
dicrocin could be the potential lead molecules which can act as 
inhibitors of both DHFR and AICAR transformylase like MTX. 
Uscharidin, calotropin and mauritine A may be potential lead 
molecules for inhibition of DHFR and Hecogenin may be a AICAR 
transformylase inhibitor lead molecule. These natural compounds 
could be used as templates for designing therapeutic lead molecules 
which could result in massive reductions in therapeutics 
development time. This study may be the subject to experimental 
validation and clinical trials to establish these phytochemicals as 
more potent drugs for the treatment of different autoimmune 
diseases and cancers. 
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